Corteva Agriscience and Belgium-based Globachem have entered a definitive agreement to form a joint venture focused on the development and commercialization of new formulated crop protection solutions.

The deal pairs Corteva, one of the world's largest seed and crop protection companies, with Globachem, a privately held Belgian firm specializing in the development and registration of crop protection products. The joint venture will concentrate on formulated products — finished formulations that growers apply directly — rather than active ingredients alone, a segment where formulation quality and regulatory dossiers increasingly determine input costs and market access.

For Corteva, the agreement extends a strategy of supplementing its internal research pipeline with external partnerships. Formulated solutions carry higher margins than generic actives and allow suppliers to differentiate products on application efficiency, tank-mix compatibility, and dose rates — factors that directly affect per-acre chemical costs for growers.

The companies have not disclosed financial terms of the transaction, nor have they detailed which product lines, crops, or regions the joint venture will target first. The agreement remains subject to customary closing conditions and regulatory review.

Industry attention will now turn to how the venture's portfolio fits alongside Corteva's existing crop protection lines and whether Globachem's registration capabilities can shorten the timeline for bringing new formulations to major agricultural markets. Regulatory approval timelines and data requirements in the EU and the US remain the key variables for when growers could see the first products reach the market.